Collective Bargaining Seen As Boon To Science Salaries

Physics professors, on the average, are paid higher salaries than their biology, chemistry, and mathematics counterparts. And full professors in all scientific disciplines tend to earn more in private colleges and universities than those in state-supported institutions. However, the scientists in more than one-third of those state-supported schools—including the physicists—would be making a lot less money than they do now if it weren’t for collective bargaining. These are a

Written bySusan Milius
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Physics professors, on the average, are paid higher salaries than their biology, chemistry, and mathematics counterparts. And full professors in all scientific disciplines tend to earn more in private colleges and universities than those in state-supported institutions. However, the scientists in more than one-third of those state-supported schools—including the physicists—would be making a lot less money than they do now if it weren’t for collective bargaining.

These are among the conclusions to be drawn from a salary report released last month by the Washington, D.C.-based College and University Personnel Association (CUPA). The report is based on a survey covering 1987-88 faculty pay scales associated with 49 disciplines—in both the sciences and humanities—at 272 state-funded colleges and universities.

According to the survey, pay rates vary with field (see chart at right), and they also vary according to the way in which contracts are negotiated. The state schools surveyed included 94 institutions— ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies